📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer. (2019)

First Author: Abubakar M

Attributed to: Improving earlier diagnosis and precision medicine for reduced mortality of breast cancer in Kenya funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41379-019-0270-4

PubMed Identifier: 30976105

Publication URI: http://europepmc.org/abstract/MED/30976105

Type: Journal Article/Review

Volume: 32

Parent Publication: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Issue: 9

ISSN: 0893-3952